CUSIP: 45168K405
Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / COM PAR
-
Total 13F shares
-
8,826,088
-
Share change
-
-14,694
-
Total reported value
-
$18,886,013
-
Put/Call ratio
-
0%
-
Price per share
-
$2.14
-
Number of holders
-
37
-
Value change
-
+$11,404
-
Number of buys
-
13
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 45168K405?
CUSIP 45168K405 identifies IDRA - IDERA PHARMACEUTICALS INC - COM PAR in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2020
-
Previous quarter:
Q2 2020
Recent filing periods for CUSIP 45168K405:
Institutional Holders of IDERA PHARMACEUTICALS INC - COM PAR (IDRA) as of Q3 2020
As of 30 Sep 2020,
IDERA PHARMACEUTICALS INC - COM PAR (IDRA) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
8,826,088 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, BlackRock Inc., BANK OF AMERICA CORP /DE/, MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, Qube Research & Technologies Ltd, JACOBS LEVY EQUITY MANAGEMENT, INC, and DCF Advisers, LLC.
This page lists
37
institutional shareholders reporting positions in this security
for the Q3 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.